ER study aims to uncover hidden kidney problems in kids
NCT ID NCT07543549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will observe 50 children (ages 1 month to 18 years) who come to the emergency room with kidney-related symptoms like swelling, blood in urine, or high blood pressure. Researchers want to learn which kidney diseases are most common and how children respond to initial treatment. The goal is to improve early detection and care, not to test a new drug or cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will include children aged 1 month to 18 years presenting to the emergency room of Sohag University Hospitals with clinical features suggestive of renal involvement. This includes both previously healthy children with new-onset symptoms and those with known renal diseases presenting with acute exacerbations. Patients will undergo routine clinical evaluation, laboratory investigations, and imaging as part of standard care, and will be followed during their hospital stay and after discharge.
- Ages
-
1 month to 18 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 1 month to 18 years. Presentation to the emergency room at Sohag University Hospitals with signs and/or symptoms suggestive of renal involvement (e.g., edema, hematuria, oliguria/anuria, flank pain, hypertension). Patients with a known history of renal disease presenting with acute exacerbation. Written informed consent obtained from parents or legal guardians. Exclusion Criteria: * Incomplete or missing essential clinical, laboratory, or imaging data. Refusal or inability to obtain written informed consent from parents or legal guardians. Patients with suspected renal symptoms later confirmed to have non-renal causes. Patients who received renal replacement therapy prior to presentation at another facility.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kidney diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle therapy may restore strength in dialysis patients
- Can software make hospital pharmacists faster and safer?
- Could a blood pressure pill shield blood vessels from heart attacks?
- A new tool to predict kidney failure risk in membranous nephropathy?
- Blood markers may foretell kidney trouble in lupus
- Can a kidney drug stop acute injury from becoming chronic?